Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast

Journal of Pathology

Volumn 199, Issue 3, 2003, Pages 298-308

  Amenta, Peter S ^a   Hadad, Salim ^a   Lee, Maria T ^a   Barnard, Nicola ^a   Li, Deqin ^b   Myers, Jeanne C ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Basement membrane; Breast; Collagen; In situ carcinoma; Laminin

Indexed keywords

COLLAGEN; COLLAGEN TYPE 15; COLLAGEN TYPE 19; COLLAGEN TYPE 4; LAMININ; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INFILTRATION; CARCINOGENESIS; CARCINOMA IN SITU; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; EPITHELIUM; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINEAR SYSTEM; MUSCLE TISSUE; NERVOUS TISSUE; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COLLAGEN; DISEASE PROGRESSION; FEMALE; HUMANS; LAMININ; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 0037371896     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1303     Document Type: Review

References (51)

1. Siegal GP, Barsky SH, Terranova VP, Liotta LA. Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. Invasion Metastasis 1981; 1: 54-70.
2. Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 1981; 41: 5076-5081.
3. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983; 49: 140-147.
4. Albrechtsen R, Wewer UM, Liotta LA. Basement membranes in human cancer. Path Annu 1986; 21: 251-276.
5. Chonette G, Auriol M, Tranbaloc P, Blondon J. Stromal changes in early invasive breast carcinoma: an immunohistochemical, histoenzymological and ultrastructural study. Path Res Pract 1990; 186: 70-79.
6. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest 1983; 48: 656-677.
7. Moriya T, Kasami M, Akiyama F, et al. A proposal for the histopathologic diagnosis of ductal carcinoma in situ of the breast. Breast Cancer 2000; 7: 321-325.
8. Yurchenco PD, O'Rear JJ. Basal lamina assembly. Curr Opin Biol 1994; 6: 674-681.
9. Yurchenco PD, Colognata H. Form and function: the laminin family of heterotrimers. Dev Dyn 2000; 218: 213-234.
10. Miosge N. The ultrastructural composition of basement membrane in vivo. Histol Histopathol 2001; 16: 1239-1248.
11. Myers JC, Dion AS, Abraham V, Amenta PS. Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones. Cell Tissue Res 1996; 286: 493-505.
12. Haag P, Haag PO, Peltonen S, Autio-Harmainen H, Pihlajaniemi T. Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol 1997; 150: 2075-2086.
13. Saarela J, Rehn M, Oikarinen A, et al.: The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 1998; 153: 611-628.
14. Myers JC, Li D, Bageris A, Abraham V, Dion AS, Amenta PS. Biochemical and immunohistochemical characterization of human type XIX defines a novel class of basement membrane zone collagens. Am J Pathol 1997; 151: 1729-1740.
15. Myers JC, Kivirikko S, Gordon MA, et al. Identification of a previously unrecognized human collagen chain α1(XV), characterized by extensive interruptions in the triple-helical region. Proc Natl Acad Sci USA 1992; 89: 10144-10148.
16. Oh S, Yamagata Y, Muragaki Y, Timmons S, Oooshima A, Olsen BR. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Nat Acad Sci USA 1994; 91: 4229-4233.
17. Rehn M, Pihlajaniemi T. α1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci USA 1994; 91: 4234-4238.
18. Kivirikko S, Heinamaki P, Rehu M, Honkanen N, Myers JC, Pihlajaniemi T. Primary structure of the α1 chain of human type XV collagen and exon-intron organization in the 3′ region of the corresponding gene. J. Biol Chem 1994; 269: 4773-4779.
19. Muragaki Y, Abe N, Ninomiya Y, Olsen BR, Ooshima A. The human α1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to α1(XVIII) collagen. J Biol Chem 1994; 269: 4042-4046.
20. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
21. Halfter W, Dong S, Schurer B, Cole GJ. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 1998; 39: 25404-25412.
22. Ramchandran R, Dhanabal M, Volk R, et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 1999; 255: 735-739.
23. Li D, Clark CC, Myers JC. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 2000; 275: 22339-22347.
24. Sasaki T, Larsson H, Tisl D, Claesson-Welsh L, Hohenester E, Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 2000; 301: 1179-1190.
25. Myers JC, Sun MJ, D'Ippolito JA, Jabs EW, Neilson EG, Dion AS. Human cDNA clones transcribed from an unusually high-molecular-weight RNA encode a new collagen chain. Gene 1993; 123: 211-217.
26. Myers JC, Yang H, D'Ippolito JA, Presente A, Miller MK, Dion AS. The triple-helical region of human type XIX collagen consists of multiple collagenous subdomains and exhibits limited sequence homology to α1(XVI). J Biol Chem 1994; 269: 18549-18557.
27. Inoguchi K, Yoshioka H, Khaleduzzaman M, Ninomiya Y. The mRNA for α1(XIX), a new member of the FACITs, contains a long unusual 3′ untranslated region. J. Biochem (Tokyo) 1995; 117: 137-146.
28. Willebrand D, Bosman FT, DeGoeji AFPM. Patterns of basement membrane deposition in benign and malignant breast tumors. Histopathology 1986; 10: 1231-1241.
29. Wetzels RHW, Holland R, Urbain JGM, et al. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 1989; 134: 571-579.
30. Raymond WA, Leong AS-Y. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology 1991; 23: 291-297.
31. Böcker W, Bier B, Fretag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Virchows Archive A Pathol Anat 1992; 421: 323-330.
32. Bonkhoff H, Wernt N, Dhom G, Remberger K. Distribution of basement membranes in primary and metastatic carcinomas of the prostate. Human Pathol 1992; 23: 934-939.
33. Guelstein VI, Tchypysheva TA, Ermilova VD, Ljubimov AV. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int J Cancer 1993; 53: 269-277.
34. Hewitt RE, Powe DG, Morrell K, et al. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 1997; 75: 221-229.
35. Nerlich AG, Lebeau A, Hagedorn HG, Sauer U, Scleicher ED. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Anticancer Res 1998; 18: 3515-3520.
36. Nakano S, Iyama K, Ogawa M, et al. Differential tissular expression and localization of type IV collagen α1(IV), α2(IV), α5(IV), and α6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Lab Invest 1999; 79: 281-292.
37. Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999; 34: 305-309.
38. Damiani S, Ludvikova M, Tomasic G, Bianchi S, Gown AM, Eusebi V. Myoepithelial cells and basal laminia in poorly differentiated in situ duct carcinoma of the breast. Virchows Arch 1999; 434: 227-234.
39. Amenta PS, Briggs K, Xu K, et al. Type XV collagen in human colonic adenocarcinomas has a different distribution than other basement membrane zone proteins. Hum Pathol 2000; 31: 359-366.
40. Maatta M, Virtanen I, Burgeson R, Autio-Harmainen H. Comparative analysis of the distribution of laminin chains in the basement membrane in some malignant epithelial tumors: the α1 chain of laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem 2001; 49: 711-725.
41. Zheng W, Loci LM, Cheah PL. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma. Pathology 2001; 33: 303-306.
42. Martinez-Hernandez A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest 1984; 51: 57-74.
43. Sasco AJ. Epidemiology of breast cancer: an environmental disease? APMIS 2001; 109: 321-332.
44. Li CI, Anderson BO, Porter PP, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000; 88: 2561-2569.
45. Ekblom P, Miettinen M, Forsman L, Andersson LC. Basement membrane and apocrine epithelial antigens in differential diagnosis between tubular carcinoma and sclerosing adenosis of the breast. J Clin Pathol 1984; 37: 357-363.
46. Westermarck J, Kahari V-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792.
47. Whittaker M, Ayscough A. Matrix metalloproteinases and their inhibitors: current status and future challenges. Celltransmissions 2001; 17: 3-14.
48. Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A, Lopez-Otin C. Regulation of collagenase 3 expression in human breast carcinomas is mediated by stroma-epithelial interactions. Cancer Res 1997; 57: 4882-4888.
49. Losa GA, Alini M. Sulfated proteoglycans in the extracellular matrix of human breast tissues with infiltrating carcinoma. Int J Cancer 1993; 54: 552-557.
50. Boudreau N, Bissell MJ. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 1998; 10: 640-646.
51. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol 2002; 20: 2736-2744.